Howe & Rusling Inc. reduced its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 2.2% during the 4th quarter, Holdings Channel reports. The fund owned 34,031 shares of the financial services provider’s stock after selling 771 shares during the quarter. Howe & Rusling Inc.’s holdings in CME Group were worth $7,903,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Inc. acquired a new position in CME Group during the 4th quarter worth approximately $871,063,000. Franklin Resources Inc. grew its stake in shares of CME Group by 70.4% during the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after purchasing an additional 1,003,119 shares in the last quarter. Capital Wealth Planning LLC grew its stake in shares of CME Group by 69.2% during the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after purchasing an additional 996,498 shares in the last quarter. Egerton Capital UK LLP acquired a new stake in CME Group in the fourth quarter valued at $223,967,000. Finally, Canoe Financial LP raised its stake in CME Group by 698.0% in the fourth quarter. Canoe Financial LP now owns 544,219 shares of the financial services provider’s stock valued at $126,384,000 after buying an additional 476,019 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Stock Performance
NASDAQ CME opened at $262.72 on Thursday. The stock has a market capitalization of $94.67 billion, a price-to-earnings ratio of 27.17, a PEG ratio of 6.76 and a beta of 0.53. The business’s 50 day moving average is $248.47 and its two-hundred day moving average is $235.14. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $267.91. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.
CME Group declared that its Board of Directors has authorized a share buyback program on Thursday, December 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s board of directors believes its stock is undervalued.
CME Group Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a $1.25 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 annualized dividend and a dividend yield of 1.90%. CME Group’s dividend payout ratio (DPR) is 51.71%.
Insider Buying and Selling
In other CME Group news, Director Howard J. Siegel sold 10,000 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 27,076 shares of company stock valued at $6,871,496. Corporate insiders own 0.30% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on CME shares. Oppenheimer upped their price objective on CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a research report on Monday, March 17th. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Barclays boosted their target price on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Finally, Morgan Stanley boosted their price objective on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $238.93.
Check Out Our Latest Report on CME Group
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Trading Halts Explained
- Energy Transfer: Powering Data With Dividends and Diversification
- What is the S&P/TSX Index?
- Qualcomm Stock Is Coiling for a Breakout
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.